Goldman Sachs analyst Shyam Srinivasan lowered the price target on Dr. Reddy\'s Laboratories (DRRD:IN) (NYSE: RDY) to INR1,050.00 (from INR1,075.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE